See All Slides - tctmd.com

Slides

Presentation TCT 2012

When Do I Prefer Transsubclavian/Axillary Alternative Access for TAVR?

Presenter: Jean-Claude Laborde

October 22, 2012

Presentation TCT 2012

Current Landscape: One-Year Post-Initial FDA Approval

Presenter: Susheel Kodali

October 22, 2012

Presentation TCT 2012

Structural Heart Disease Intervention: Perspectives from the Russian Federation Database

Presenter: Bagrat Alekyan

October 22, 2012

Presentation TCT 2012

Step 2: Invention

Presenter: Richard Stack

October 22, 2012

Presentation TCT 2012

The Emergence of Interventional Heart Failure and Advanced Cardiac Support as an Important Clinical Subspecialty: Clinical Targets, Device Concepts, and Physician Training

Presenter: Navin Kapur

October 22, 2012

Presentation TCT 2012

Hemodynamics of the Normal Heart from the Technologist's Perspective

Presenter: Sally Elliott

October 22, 2012

Presentation TCT 2012

Update on CCSVI: Are We Any Closer to Understanding This Entity and Its Therapy?

Presenter: Michael Dake

October 22, 2012

Presentation TCT 2012

What Definition Should Be Used to Define Periprocedural MI in Clinical Trials and Practice?

Presenter: Gregg Stone

October 22, 2012

Presentation TCT 2012

Informed Consent

Presenter: Lauren Privitera

October 22, 2012

Presentation TCT 2012

Planned Two-Stent Technique Cases 7 and 8: Mini-Crush and Culotte

Presenter: Alaide Chieffo

October 22, 2012

Advertisement

Slides

When Do I Prefer Transsubclavian/Axillary Alternative Access for TAVR?

Current Landscape: One-Year Post-Initial FDA Approval

Structural Heart Disease Intervention: Perspectives from the Russian Federation Database

Step 2: Invention

The Emergence of Interventional Heart Failure and Advanced Cardiac Support as an Important Clinical Subspecialty: Clinical Targets, Device Concepts, and Physician Training

Hemodynamics of the Normal Heart from the Technologist's Perspective

Update on CCSVI: Are We Any Closer to Understanding This Entity and Its Therapy?

What Definition Should Be Used to Define Periprocedural MI in Clinical Trials and Practice?

Informed Consent

Planned Two-Stent Technique Cases 7 and 8: Mini-Crush and Culotte

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content